Ginkgo Bioworks Holdings (DNA) Raw Materials (2021 - 2023)

Ginkgo Bioworks Holdings posted quarterly Raw Materials of $905000.0 for Q2 2023, up 4.87% year-on-year from $863000.0 in Q2 2022, and down 59.94% on a QoQ basis from $2.3 million in Q1 2023.

Ginkgo Bioworks Holdings (DNA) has 3 years of Raw Materials data on file, last reported at $905000.0 in Q2 2023.

  • For the quarter ending Q2 2023, Raw Materials rose 4.87% year-over-year to $905000.0; the trailing twelve-month figure through Jun 2023 stood at $905000.0 (up 4.87% YoY), and the FY2022 full-year result was $1.6 million, up 2384.38% from the prior year.
  • Raw Materials for Q2 2023 stood at $905000.0, down from $2.3 million in the prior quarter.
  • Across five years, Raw Materials topped out at $2.3 million in Q1 2023 and bottomed at $64000.0 in Q4 2021.
  • The 3-year median for Raw Materials is $884000.0 (2022), against an average of $1.1 million.
  • The widest annual swing landed in 2022, when Raw Materials soared 2384.38%; it then climbed 4.87% in 2023.
  • A 3-year view of Raw Materials shows it stood at $64000.0 in 2021, then jumped by 2384.38% to $1.6 million in 2022, then slumped by 43.08% to $905000.0 in 2023.
  • The last three Raw Materials figures came in at $905000.0 (Q2 2023), $2.3 million (Q1 2023), and $1.6 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ginkgo Bioworks Holdings 542.03 Mn 542.03 Mn 16.38 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 905,000.00
Mar 31, 2023 2.26 Mn
Dec 31, 2022 1.59 Mn
Sep 30, 2022 1.28 Mn
Jun 30, 2022 863,000.00
Mar 31, 2022 799,000.00
Dec 31, 2021 64,000.00
Sep 30, 2021 828,000.00